How much did Healios KK achieve in EBIT for the current year?
In the current year, Healios KK has achieved an EBIT of 0 JPY.
Healios KK EBIT 2024
Healios KK EBIT
0 JPY
Ticker
4593.T
ISIN
JP3835100003
WKN
A14U80
In 2024, Healios KK's EBIT was 0 JPY, a 0% increase from the -3.38 B JPY EBIT recorded in the previous year.
The Healios KK EBIT history
| YEAR | EBIT (undefined JPY) |
|---|---|
| 2026e | - |
| 2025e | - |
| 2024e | - |
| 2023 | -3,380 |
| 2022 | -5,157 |
| 2021 | -5,379 |
| 2020 | -4,196 |
| 2019 | -4,305 |
| 2018 | -5,063 |
| 2017 | -2,348.21 |
| 2016 | -3,507.46 |
| 2015 | -1,060.42 |
| 2014 | -573.42 |
| 2013 | 195 |
Healios KK Revenue, EBIT, Net Income JP3835100003 · A14U80
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Healios KK, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Healios KK from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Healios KK’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Healios KK. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Healios KK’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Healios KK’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Healios KK’s growth potential.
Healios KK Revenue, EBIT and net profit per share
| Date | Healios KK Revenue | Healios KK EBIT | Healios KK Net Income |
|---|---|---|---|
| 2026e | 1.82 B undefined | 0 undefined | -2.92 B undefined |
| 2025e | 1.12 B undefined | 0 undefined | -2.66 B undefined |
| 2024e | 661.55 M undefined | 0 undefined | -3.25 B undefined |
| 2023 | 121 M undefined | -3.38 B undefined | -3.82 B undefined |
| 2022 | 90 M undefined | -5.16 B undefined | -5.17 B undefined |
| 2021 | 41 M undefined | -5.38 B undefined | -4.91 B undefined |
| 2020 | 27 M undefined | -4.2 B undefined | -5.51 B undefined |
| 2019 | 89 M undefined | -4.31 B undefined | -4.81 B undefined |
| 2018 | 0 undefined | -5.06 B undefined | -5.1 B undefined |
| 2017 | 27.67 M undefined | -2.35 B undefined | -1.78 B undefined |
| 2016 | 77.64 M undefined | -3.51 B undefined | -3.43 B undefined |
| 2015 | 98.17 M undefined | -1.06 B undefined | -958.1 M undefined |
| 2014 | 280 M undefined | -573.42 M undefined | -480.71 M undefined |
| 2013 | 500 M undefined | 195 M undefined | 85.1 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2013 | 500 M JPY | 195 M JPY | 85.1 M JPY |
| 2014 | 280 M JPY | -573.42 M JPY | -480.71 M JPY |
| 2015 | 98.17 M JPY | -1.06 B JPY | -958.1 M JPY |
| 2016 | 77.64 M JPY | -3.51 B JPY | -3.43 B JPY |
| 2017 | 27.67 M JPY | -2.35 B JPY | -1.78 B JPY |
| 2018 | 0 JPY | -5.06 B JPY | -5.1 B JPY |
| 2019 | 89 M JPY | -4.31 B JPY | -4.81 B JPY |
| 2020 | 27 M JPY | -4.2 B JPY | -5.51 B JPY |
| 2021 | 41 M JPY | -5.38 B JPY | -4.91 B JPY |
| 2022 | 90 M JPY | -5.16 B JPY | -5.17 B JPY |
| 2023 | 121 M JPY | -3.38 B JPY | -3.82 B JPY |
| 2024e | 661.55 M JPY | 0 JPY | -3.25 B JPY |
| 2025e | 1.12 B JPY | 0 JPY | -2.66 B JPY |
| 2026e | 1.82 B JPY | 0 JPY | -2.92 B JPY |
Healios KK stock margins JP3835100003 · A14U80
The Healios KK margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Healios KK. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Healios KK.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Healios KK's sales revenue. A higher gross margin percentage indicates that the Healios KK retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Healios KK's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Healios KK's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Healios KK's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Healios KK. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Healios KK's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Healios KK Margin History
| Healios KK Gross margin | Healios KK Profit margin | Healios KK EBIT margin | Healios KK Profit margin |
|---|---|---|---|
| 2026e | 89.26 % | 0 % | -160.3 % |
| 2025e | 89.26 % | 0 % | -238.18 % |
| 2024e | 89.26 % | 0 % | -491.24 % |
| 2023 | 89.26 % | -2,793.39 % | -3,159.5 % |
| 2022 | 89.26 % | -5,730 % | -5,743.33 % |
| 2021 | 89.26 % | -13,119.51 % | -11,975.61 % |
| 2020 | 89.26 % | -15,540.74 % | -20,414.82 % |
| 2019 | 89.26 % | -4,837.08 % | -5,400 % |
| 2018 | 89.26 % | 0 % | 0 % |
| 2017 | 88 % | -8,487.7 % | -6,421.79 % |
| 2016 | 88.22 % | -4,517.6 % | -4,422.4 % |
| 2015 | 90.43 % | -1,080.22 % | -975.99 % |
| 2014 | 82.42 % | -204.8 % | -171.68 % |
| 2013 | 100 % | 39 % | 17.02 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2013 | 100 % | 39 % | 17.02 % |
| 2014 | 82.42 % | -204.8 % | -171.68 % |
| 2015 | 90.43 % | -1,080.22 % | -975.99 % |
| 2016 | 88.22 % | -4,517.6 % | -4,422.4 % |
| 2017 | 88 % | -8,487.7 % | -6,421.79 % |
| 2018 | 89.26 % | 0 % | 0 % |
| 2019 | 89.26 % | -4,837.08 % | -5,400 % |
| 2020 | 89.26 % | -15,540.74 % | -20,414.82 % |
| 2021 | 89.26 % | -13,119.51 % | -11,975.61 % |
| 2022 | 89.26 % | -5,730 % | -5,743.33 % |
| 2023 | 89.26 % | -2,793.39 % | -3,159.5 % |
| 2024e | 89.26 % | 0 % | -491.24 % |
| 2025e | 89.26 % | 0 % | -238.18 % |
| 2026e | 89.26 % | 0 % | -160.3 % |
Healios KK Aktienanalyse
What does Healios KK do?
Healios KK is a Japanese company founded in 2011. It focuses on the development of neuroscience, particularly the treatment of central nervous system disorders. Healios KK is headquartered in Tokyo and currently employs approximately 100 employees. Business Model: Healios KK aims to develop and market innovative treatments for patients with neurological disorders. The company works closely with research institutes, universities, and other companies to make progress in the development of new drugs and therapies. Healios KK is also involved in clinical research and works to translate its research findings into new products. Divisions: The company focuses on four main areas: - Regenerative Medicine - Stem Cell Therapy - Brain-Computer Interfaces - AI-supported Diagnosis Regenerative Medicine: Healios KK researches new technologies for the treatment of neurological disorders through regenerative medicine, particularly through stem cell therapy. The company collaborates closely with researchers to develop groundbreaking technologies that support the healing of nerve cells and promote brain regeneration. Stem Cell Therapy: Healios KK also focuses on stem cell therapy, which is being investigated in the company's research labs to find new treatment options for patients with spinal injuries, strokes, Parkinson's, and other neurological disorders. Stem cell therapy involves using stem cells to regenerate damaged tissue in the brain or spinal cord. Brain-Computer Interfaces: Healios KK is also working on the development of brain-computer interfaces (BCIs) that aim to establish a direct connection between the brain and a computer. With the help of these interfaces, patients with paralysis or certain neurological disorders can regain control over their movements and activities. Healios KK has developed a smartglove that can be controlled using BCI. AI-supported Diagnosis: Using state-of-the-art artificial intelligence (AI) technologies, Healios KK is developing new and more effective diagnostic methods for neurological disorders. By developing algorithms based on brain scan images, AI-supported diagnoses are expected to be faster and more effective in the future. Products: Healios KK offers a wide range of products and therapies to effectively treat patients with neurological disorders. These include: - Stem Cell Therapy: The company develops and distributes stem cell therapies to treat patients with spinal injuries, strokes, and other neurological disorders. - Smartglove: Healios KK has developed an intelligent glove that is controlled through brain-computer interfaces. The glove is intended for patients who are unable to move their hands due to paralysis. - AI-supported Diagnosis: The company is working on computer-assisted diagnoses of neurological disorders that are more effective and accurate than conventional diagnoses. - Clinical Trials: Healios KK also conducts clinical trials to investigate the effectiveness of new therapies and treatment methods. Summary: Healios KK is a Japanese company focused on developing innovative therapies and treatment methods for neurological disorders. The company works closely with research institutes and other companies to make progress in the development of new drugs and therapies. Healios KK has four main divisions: Regenerative Medicine, Stem Cell Therapy, Brain-Computer Interfaces, and AI-supported Diagnosis. The company offers a variety of products, including stem cell therapy, smartgloves, and AI-supported diagnoses. Healios KK aims to enhance the lives of patients with neurological disorders by using innovative technologies to support their health. Healios KK ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Healios KK's EBIT
Healios KK's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Healios KK's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Healios KK's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Healios KK’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Healios KK stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Healios KK.
How has the EBIT of Healios KK developed in recent years?
The EBIT of Healios KK has increased by 0% decreased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Healios KK?
The EBIT of Healios KK is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Healios KK pay?
Over the past 12 months, Healios KK paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Healios KK is expected to pay a dividend of 0 JPY.
What is the dividend yield of Healios KK?
The current dividend yield of Healios KK is .
When does Healios KK pay dividends?
Healios KK pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Healios KK?
Healios KK paid dividends every year for the past 0 years.
What is the dividend of Healios KK?
For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.
In which sector is Healios KK located?
Healios KK is assigned to the 'Health' sector.
Wann musste ich die Aktien von Healios KK kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Healios KK from 8/15/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 8/15/2024.
When did Healios KK pay the last dividend?
The last dividend was paid out on 8/15/2024.
What was the dividend of Healios KK in the year 2023?
In the year 2023, Healios KK distributed 0 JPY as dividends.
In which currency does Healios KK pay out the dividend?
The dividends of Healios KK are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Healios KK
Our stock analysis for Healios KK Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Healios KK Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
